New England Journal of Medicine· 2020Q1
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
- 2,259citations
- Q1SCImago
- 2020year
Short summary
Three critically ill patients with COVID-19 presented with coagulopathy and antiphospholipid antibodies.
AI-generated from the title and abstract; the full text is not read.
Key points
- Three critically ill COVID-19 patients were observed.
- All patients presented with coagulopathy.
- Antiphospholipid antibodies were detected in all three patients.
AI-generated from the title and abstract; the full text is not read.
Abstract
The authors describe a 69-year-old man with Covid-19 diagnosed in January 2020 in Wuhan, China, along with two other critically ill patients with Covid-19 who were also seen in the same intensive care unit. Coagulopathy and antiphospholipid antibodies were seen in all three patients.
The authors' abstract, as published at the source. New England Journal of Medicine, 2020 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Rheumatology
RheumatologyMedicine